Intuitive Surgical stock heads into the open after a 1.9 percent dip

At the close on September 9, 2026, Intuitive Surgical stock finished near USD 351 on the Nasdaq, down about 1.9 percent, while remaining well above its recent lows. The move followed robust quarterly results that topped expectations and highlighted double-digit revenue growth.

At the close on September 9, 2026, Intuitive Surgical stock finished at USD 351.13 on the Nasdaq, down 1.9 percent from the prior session in a volatile trading day. Compared with its average analyst price target of USD 508.68, the close left the shares trading roughly 45 percent below that level, underscoring a wide gap between market price and analyst expectations as noted by Ad-hoc-news. The latest quarterly figures, including revenue of USD 2.89 billion and adjusted earnings per share of USD 2.80 for the recent reporting period, continued to frame investor sentiment ahead of today's session.

September 9, 2026 in numbers

Intuitive Surgical Inc. (ISIN US46120E6023, Nasdaq: ISRG) has recently reported revenue of USD 2.89 billion for its latest quarter, up 18.5 percent year on year, with adjusted earnings per share of USD 2.80, beating analyst expectations according to Yahoo Finance. In the session that followed on September 9, 2026, the shares closed at USD 351.13 on the Nasdaq, while intra-day levels stayed within a range consistent with the recent 52-week band per Nasdaq data from major quote services. Trading volume in that session was in line with recent averages, and the stock remained comfortably above its 52-week low, even after the post-earnings pullback highlighted by Yahoo Finance. On a relative basis, the share price performance lagged the broader S&P 500 over the period since the report, with the stock down more than 12 percent from the earnings release while the index showed a more moderate move in the same stretch.

Events around today

Today, Intuitive Surgical heads into the US session without a scheduled earnings release, following the recent quarterly update that has already set the tone for near-term expectations as reported by Yahoo Finance. Broader equity market conditions after September 9, 2026 remain an additional reference point, with major US indices recently experiencing choppy trading, as summarized by Zacks, a backdrop that can influence sentiment toward higher-valuation growth and medical technology names such as Intuitive Surgical. With the latest quarterly beat and subsequent share-price consolidation still fresh, analysts and investors focus on procedure growth trends and capital equipment demand as key themes that could shape trading dynamics over the coming sessions.